Yali Biosciences
Latest round
- Seed
Last raised
- Feb 2022
Total raised
- $3.9M
Investors
- 8
About Yali Biosciences
Founded in 2021 and based in California, US, Yali Biosciences Inc. operates as a provider of designer fats for plant-based meat and dairy products. In February 2022, Yali Biosciences Inc. Yali Biosciences Inc. provides synthetic biology platform to make food compositions from renewable feedstocks for a range of sustainable foods. The company combines synthetic biology, deep learning, and genomics tools to produce sustainable fats in plant proteins. The company's technology enables them to develop a pipeline of plant-based fats that emulate animal fats used for various applications including different cuts of steak that have varying fat compositions.
Who invested in Yali Biosciences
8 investors across 2 rounds
See all investors in Yali Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Yali Biosciences
Who invested in Yali Biosciences?
Yali Biosciences has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Yali Biosciences raised?
Yali Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Yali Biosciences last raise money?
Yali Biosciences's most recent round on record is a Seed, in Feb 2022.
What does Yali Biosciences do?
Founded in 2021 and based in California, US, Yali Biosciences Inc.
Where is Yali Biosciences headquartered?
Yali Biosciences is headquartered in South San Francisco, US.
Which VCs invest in companies like Yali Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Yali Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Yali Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.